{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:18:07Z","timestamp":1793643487524,"version":"4.5.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["7222141"],"award-info":[{"award-number":["7222141"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-C&T-B-040"],"award-info":[{"award-number":["2021-I2M-C&T-B-040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In recent years, extracorporeal membrane oxygenation (ECMO) has been increasingly used in critically ill patients with respiratory or cardiac failure. Heparin is usually used as anticoagulation therapy during ECMO support. However, heparin-induced thrombocytopenia (HIT) in ECMO-supported patients, which results in considerable morbidity and mortality, has not yet been well described. This meta-analysis and systematic review aimed to thoroughly report the incidence of HIT on ECMO, as well as the characteristics and outcomes of HIT patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched the PubMed, Embase, Cochrane Library, and Scopus databases for studies investigating HIT in adult patients supported by ECMO. All studies conforming to the inclusion criteria were screened from 1975 to August 2023. Nineteen studies from a total of 1,625 abstracts were selected. The primary outcomes were the incidence of HIT and suspected HIT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The pooled incidence of HIT in ECMO-supported patients was 4.2% (95% CI: 2.7\u20135.6; 18 studies). A total of 15.9% (95% CI: 9.0-22.8; 12 studies) of patients on ECMO were suspected of having HIT. Enzyme-linked immunosorbent assay (ELISA) is the most commonly used immunoassay. The median optical density (OD) of the ELISA in HIT-confirmed patients ranged from 1.08 to 2.10. In most studies, the serotonin release assay (SRA) was performed as a HIT-confirming test. According to the subgroup analysis, the pooled incidence of HIT in ECMO patients was 2.7% in studies whose diagnostic mode was functional assays, which is significantly lower than the incidence in studies in which the patients were diagnosed by immunoassay (14.5%). Argatroban was most commonly used as an alternative anticoagulation agent after the withdrawal of heparin. Among confirmed HIT patients, 45.5% (95% CI: 28.8\u201362.6) experienced thrombotic events, while 50.1% (95% CI: 24.9\u201375.4) experienced bleeding events. Overall, 46.6% (95% CI: 30.4\u201363.1) of patients on ECMO with HIT died.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>According to our study, the pooled incidence of HIT in ECMO-supported patients is 4.2%, and it contributes to adverse outcomes. Inappropriate diagnostic methods can easily lead to misdiagnosis of HIT. Further research and development of diagnostic algorithms and laboratory assays are warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12959-024-00624-5","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:01:49Z","timestamp":1719529309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Danyu","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"issue":"24","key":"624_CR1","first-page":"2536","volume":"323","author":"J Hadaya","year":"2020","unstructured":"Hadaya J, Benharash P. Extracorpor Membrane Oxygenation Jama. 2020;323(24):2536.","journal-title":"Extracorpor Membrane Oxygenation Jama"},{"issue":"2","key":"624_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tmrv.2014.12.001","volume":"29","author":"DA Murphy","year":"2015","unstructured":"Murphy DA, Hockings LE, Andrews RK, et al. Extracorporeal membrane oxygenation-hemostatic complications. Transfus Med Rev. 2015;29(2):90\u2013101.","journal-title":"Transfus Med Rev"},{"issue":"3","key":"624_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","volume":"68","author":"ABV McMichael","year":"2022","unstructured":"McMichael ABV, Ryerson LM, Ratano D, Fan E, Faraoni D, Annich GM. 2021 ELSO Adult and Pediatric Anticoagulation guidelines. Asaio j. 2022;68(3):303\u201310.","journal-title":"Asaio j"},{"issue":"6","key":"624_CR4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s00134-020-06031-4","volume":"46","author":"F Jiritano","year":"2020","unstructured":"Jiritano F, Serraino GF, Ten Cate H, et al. Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis. Intensive Care Med. 2020;46(6):1154\u201369.","journal-title":"Intensive Care Med"},{"issue":"2","key":"624_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1358863X19898253","volume":"25","author":"M Hogan","year":"2020","unstructured":"Hogan M, Berger JS. Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management. Vasc Med. 2020;25(2):160\u201373.","journal-title":"Vasc Med"},{"key":"624_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fcvm.2019.00114","volume":"6","author":"CM Balle","year":"2019","unstructured":"Balle CM, Jeppesen AN, Christensen S, Hvas AM. Platelet function during extracorporeal membrane oxygenation in adult patients. Front Cardiovasc Med. 2019;6:114.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"624_CR7","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1016\/S2352-3026(18)30046-2","volume":"5","author":"B Dhakal","year":"2018","unstructured":"Dhakal B, Kreuziger LB, Rein L, et al. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study. Lancet Haematol. 2018;5(5):e220\u201331.","journal-title":"Lancet Haematol"},{"issue":"6","key":"624_CR8","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jcrc.2015.07.030","volume":"30","author":"D Glick","year":"2015","unstructured":"Glick D, Dzierba AL, Abrams D, et al. Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation. J Crit Care. 2015;30(6):1190\u20134.","journal-title":"J Crit Care"},{"issue":"13\u201314","key":"624_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00508-016-1109-3","volume":"129","author":"M Kutle\u0161a","year":"2017","unstructured":"Kutle\u0161a M, Novokmet A, Josipovi\u0107 Mraovi\u0107 R, Bar\u0161i\u0107 B. Venovenous extracorporeal membrane oxygenation for ARDS: outcome analysis of a Croatian referral center for respiratory ECMO. Wiener Klinische Wochenschrift. 2017;129(13\u201314):497\u2013502.","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"9","key":"624_CR10","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1007\/s00134-018-5346-y","volume":"44","author":"A Kimmoun","year":"2018","unstructured":"Kimmoun A, Oulehri W, Sonneville R, et al. Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study. Intensive Care Med. 2018;44(9):1460\u20139.","journal-title":"Intensive Care Med"},{"issue":"7","key":"624_CR11","first-page":"584","volume":"34","author":"D Pabst","year":"2019","unstructured":"Pabst D, Boone JB, Soleimani B, Brehm CE. Heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation and the role of a heparin-bonded circuit. Perfusion (United Kingdom). 2019;34(7):584\u20139.","journal-title":"Perfusion (United Kingdom)"},{"issue":"7","key":"624_CR12","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1055\/s-0039-1688827","volume":"119","author":"C Vayne","year":"2019","unstructured":"Vayne C, May MA, Bourguignon T, et al. Frequency and clinical impact of platelet factor 4-Specific antibodies in patients undergoing extracorporeal membrane oxygenation. Thromb Haemost. 2019;119(7):1138\u201346.","journal-title":"Thromb Haemost"},{"key":"624_CR13","doi-asserted-by":"crossref","unstructured":"Arachchillage DRJ, Laffan M, Khanna S et al. Frequency of Thrombocytopenia and Heparin-Induced Thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of Pretest Probability score. Crit Care Med. 2020:E371\u20139.","DOI":"10.1097\/CCM.0000000000004261"},{"key":"624_CR14","doi-asserted-by":"crossref","unstructured":"Kataria V, Moore L, Harrison S, Hernandez O, Vaughan N, Schwartz G. Evaluation of serotonin release assay and enzyme-linked immunosorbent assay optical density thresholds for heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation. Crit Care Med. 2020:E82\u20136.","DOI":"10.1097\/CCM.0000000000004090"},{"issue":"5","key":"624_CR15","first-page":"378","volume":"35","author":"J Sullivan","year":"2020","unstructured":"Sullivan J, Bak E, Sullivan MJ, Gurnani PK. Predictive value of scoring tools in determining heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation. Perfusion (United Kingdom). 2020;35(5):378\u201383.","journal-title":"Perfusion (United Kingdom)"},{"issue":"5","key":"624_CR16","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.athoracsur.2019.08.040","volume":"109","author":"KL Wood","year":"2020","unstructured":"Wood KL, Ayers B, Gosev I, et al. Venoarterial-extracorporeal membrane oxygenation without routine systemic anticoagulation decreases adverse events. Ann Thorac Surg. 2020;109(5):1458\u201366.","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"624_CR17","first-page":"688","volume":"36","author":"M Mazzeffi","year":"2021","unstructured":"Mazzeffi M, Clark M, Grazioli A, et al. Platelet factor-4 concentration in adult veno-arterial ECMO patients. Perfusion (United Kingdom). 2021;36(7):688\u201393.","journal-title":"Perfusion (United Kingdom)"},{"issue":"7","key":"624_CR18","doi-asserted-by":"publisher","first-page":"e0485","DOI":"10.1097\/CCE.0000000000000485","volume":"3","author":"K Giuliano","year":"2021","unstructured":"Giuliano K, Bigelow BF, Etchill EW, et al. Extracorporeal membrane oxygenation complications in heparin- and bivalirudin-treated patients. Crit care Explor. 2021;3(7):e0485.","journal-title":"Crit care Explor"},{"issue":"2","key":"624_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11239-021-02546-9","volume":"53","author":"AM Zaaqoq","year":"2022","unstructured":"Zaaqoq AM, Brammer RC, Chan CM, Shorr AF. Heparin-induced thrombocytopenia in extra-corporeal membrane oxygenation: epidemiology, outcomes, and diagnostic challenges. J Thromb Thrombolysis. 2022;53(2):499\u2013505.","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"624_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bjh.17870","volume":"196","author":"DJ Arachchillage","year":"2022","unstructured":"Arachchillage DJ, Rajakaruna I, Scott I, et al. Impact of major bleeding and thrombosis on 180-day survival in patients with severe COVID-19 supported with veno-venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study. Br J Haematol. 2022;196(3):566\u201376.","journal-title":"Br J Haematol"},{"issue":"8","key":"624_CR21","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1177\/03913988221106225","volume":"45","author":"DJ Hanna","year":"2022","unstructured":"Hanna DJ, Torbic H, Militello M, Strnad K, Krishnan S, Hohlfelder B. Evaluation of anticoagulation with bivalirudin for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation. Int J Artif Organs. 2022;45(8):688\u201394.","journal-title":"Int J Artif Organs"},{"issue":"7","key":"624_CR22","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1053\/j.jvca.2022.02.030","volume":"36","author":"SJ Kram","year":"2022","unstructured":"Kram SJ, Hamidi A, Kram BL, Arepally G, Levy JH. The predictive value of the 4Ts and HEP score at recommended cutoffs in patients with mechanical circulatory support devices. J Cardiothorac Vasc Anesth. 2022;36(7):1873\u20139.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"8","key":"624_CR23","doi-asserted-by":"publisher","first-page":"e0272577","DOI":"10.1371\/journal.pone.0272577","volume":"17","author":"M Lubnow","year":"2022","unstructured":"Lubnow M, Berger J, Schneckenpointner R, et al. Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation. PLoS ONE. 2022;17(8):e0272577.","journal-title":"PLoS ONE"},{"issue":"8","key":"624_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/MAT.0000000000001733","volume":"68","author":"S Mang","year":"2022","unstructured":"Mang S, Danziger G, Metz C, et al. Injection of recombinant tissue plasminogen activator into extracorporeal membrane oxygenators postpones Oxygenator Exchange in COVID-19. ASAIO J. 2022;68(8):1017\u201323.","journal-title":"ASAIO J"},{"issue":"4","key":"624_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/03913988231163891","volume":"46","author":"M Kutle\u0161a","year":"2023","unstructured":"Kutle\u0161a M, Santini M, Krajinovi\u0107 V, et al. Extracorporeal membrane oxygenation in COVID-19: results of the Croatian extracorporeal membrane oxygenation Referral Center. Int J Artif Organs. 2023;46(4):248\u201351.","journal-title":"Int J Artif Organs"},{"key":"624_CR26","doi-asserted-by":"crossref","unstructured":"L\u00fcsebrink E, Scherer C, Binzenh\u00f6fer L et al. Heparin-Induced Thrombocytopenia in patients undergoing venoarterial extracorporeal membrane oxygenation. J Clin Med. 2023;12(1).","DOI":"10.3390\/jcm12010362"},{"issue":"21","key":"624_CR27","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.jacc.2016.02.073","volume":"67","author":"BS Salter","year":"2016","unstructured":"Salter BS, Weiner MM, Trinh MA, et al. Heparin-Induced Thrombocytopenia: a Comprehensive Clinical Review. J Am Coll Cardiol. 2016;67(21):2519\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"624_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev.med.042808.171814","volume":"61","author":"GM Arepally","year":"2010","unstructured":"Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. Annu Rev Med. 2010;61:77\u201390.","journal-title":"Annu Rev Med"},{"issue":"4","key":"624_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1053\/j.jvca.2011.11.009","volume":"26","author":"P Piednoir","year":"2012","unstructured":"Piednoir P, Allou N, Provench\u00e8re S, et al. Heparin-induced thrombocytopenia after cardiac surgery: an observational study of 1,722 patients. J Cardiothorac Vasc Anesth. 2012;26(4):585\u201390.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"624_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.injury.2011.05.007","volume":"43","author":"A Bloemen","year":"2012","unstructured":"Bloemen A, Testroote MJ, Janssen-Heijnen ML, Janzing HM. Incidence and diagnosis of heparin-induced thrombocytopenia (HIT) in patients with traumatic injuries treated with unfractioned or low-molecular-weight heparin: a literature review. Injury. 2012;43(5):548\u201352.","journal-title":"Injury"},{"issue":"1","key":"624_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11239-017-1494-0","volume":"44","author":"J Bain","year":"2017","unstructured":"Bain J, Flannery AH, Flynn J, Dager W. Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations. J Thromb Thrombolysis. 2017;44(1):76\u201387.","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"624_CR32","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","volume":"4","author":"GK Lo","year":"2006","unstructured":"Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759\u201365.","journal-title":"J Thromb Haemost"},{"issue":"12","key":"624_CR33","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1111\/j.1538-7836.2010.04059.x","volume":"8","author":"A Cuker","year":"2010","unstructured":"Cuker A, Arepally G, Crowther MA, et al. The HIT Expert Probability (HEP) score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost. 2010;8(12):2642\u201350.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"624_CR34","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/j.1538-7836.2004.00949.x","volume":"2","author":"A Lillo-Le Lou\u00ebt","year":"2004","unstructured":"Lillo-Le Lou\u00ebt A, Boutouyrie P, Alhenc-Gelas M, et al. Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost. 2004;2(11):1882\u20138.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"624_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/14737159.2017.1304213","volume":"17","author":"M Nagler","year":"2017","unstructured":"Nagler M, Cuker A. Profile of Instrumentation Laboratory\u2019s HemosIL\u00ae AcuStar HIT-Ab(PF4-H) assay for diagnosis of heparin-induced thrombocytopenia. Expert Rev Mol Diagn. 2017;17(5):419\u201326.","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"624_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/ajh.24006","volume":"90","author":"TE Warkentin","year":"2015","unstructured":"Warkentin TE, Arnold DM, Nazi I, Kelton JG. The platelet serotonin-release assay. Am J Hematol. 2015;90(6):564\u201372.","journal-title":"Am J Hematol"},{"issue":"1","key":"624_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1182\/asheducation-2016.1.262","volume":"2016","author":"O Onwuemene","year":"2016","unstructured":"Onwuemene O, Arepally GM. Heparin-induced thrombocytopenia: research and clinical updates. Hematol Am Soc Hematol Educ Program. 2016;2016(1):262\u20138.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"17","key":"624_CR38","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","volume":"344","author":"TE Warkentin","year":"2001","unstructured":"Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001;344(17):1286\u201392.","journal-title":"N Engl J Med"},{"issue":"11","key":"624_CR39","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1097\/CCM.0000000000001869","volume":"44","author":"M Sokolovic","year":"2016","unstructured":"Sokolovic M, Pratt AK, Vukicevic V, Sarumi M, Johnson LS, Shah NS. Platelet count trends and Prevalence of Heparin-Induced Thrombocytopenia in a cohort of extracorporeal membrane oxygenator patients. Crit Care Med. 2016;44(11):e1031\u20137.","journal-title":"Crit Care Med"},{"issue":"1","key":"624_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21037\/acs.2018.12.02","volume":"8","author":"JH Choi","year":"2019","unstructured":"Choi JH, Luc JGY, Weber MP, et al. Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes. Ann Cardiothorac Surg. 2019;8(1):19\u201331.","journal-title":"Ann Cardiothorac Surg"},{"issue":"6","key":"624_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1365-2141.2005.05381.x","volume":"128","author":"C Pouplard","year":"2005","unstructured":"Pouplard C, May MA, Regina S, Marchand M, Fusciardi J, Gruel Y. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol. 2005;128(6):837\u201341.","journal-title":"Br J Haematol"},{"issue":"11","key":"624_CR42","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/aor.12527","volume":"39","author":"JB Clark","year":"2015","unstructured":"Clark JB, Wang S, Palanzo DA, et al. Current techniques and outcomes in extracorporeal life support. Artif Organs. 2015;39(11):926\u201330.","journal-title":"Artif Organs"},{"issue":"2 Suppl","key":"624_CR43","doi-asserted-by":"publisher","first-page":"eS495","DOI":"10.1378\/chest.11-2303","volume":"141","author":"LA Linkins","year":"2012","unstructured":"Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):eS495\u2013530.","journal-title":"Chest"},{"key":"624_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.thromres.2021.12.024","volume":"210","author":"DH Li","year":"2022","unstructured":"Li DH, Sun MW, Zhang JC, Zhang C, Deng L, Jiang H. Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis. Thromb Res. 2022;210:53\u201362.","journal-title":"Thromb Res"},{"issue":"2","key":"624_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/1060028014562949","volume":"49","author":"QA Vo","year":"2015","unstructured":"Vo QA, Lin JK, Tong LM. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia. Ann Pharmacother. 2015;49(2):178\u201384.","journal-title":"Ann Pharmacother"},{"issue":"22","key":"624_CR46","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","volume":"2","author":"A Cuker","year":"2018","unstructured":"Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360\u201392.","journal-title":"Blood Adv"},{"issue":"5","key":"624_CR47","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/bja\/aeg063","volume":"90","author":"E Pravinkumar","year":"2003","unstructured":"Pravinkumar E, Webster NR. HIT\/HITT and alternative anticoagulation: current concepts. Br J Anaesth. 2003;90(5):676\u201385.","journal-title":"Br J Anaesth"},{"issue":"11","key":"624_CR48","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jchf.2020.09.004","volume":"8","author":"M Chung","year":"2020","unstructured":"Chung M, Cabezas FR, Nunez JI, et al. Hemocompatibility-related adverse events and survival on venoarterial extracorporeal life support: an ELSO Registry Analysis. JACC Heart Fail. 2020;8(11):892\u2013902.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"624_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00134-021-06593-x","volume":"48","author":"JI Nunez","year":"2022","unstructured":"Nunez JI, Gosling AF, O\u2019Gara B, et al. Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis. Intensive Care Med. 2022;48(2):213\u201324.","journal-title":"Intensive Care Med"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-024-00624-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-024-00624-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-024-00624-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:02:02Z","timestamp":1719529322000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-024-00624-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1186\/s12959-024-00624-5","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}